Related Experiment Videos
Treating hypertension. A review of clinical trials
Insights
Clinical trials evaluate antihypertensive therapy for high blood pressure, aiming to reduce cardiovascular and cerebrovascular disease. Further analysis beyond mortality is needed for practical treatment decisions.
Area of Science:
- Cardiology
- Clinical Trials Methodology
- Public Health
Background:
- Antihypertensive therapy is crucial for managing high blood pressure.
- Clinical trials are the standard for evaluating chronic disease treatments.
- Hypertension management impacts cardiovascular and cerebrovascular disease outcomes.
Purpose of the Study:
- To assess the effectiveness of antihypertensive therapy.
- To review the implications of hypertension clinical trials.
- To determine how trial results can inform physician treatment decisions.
Main Methods:
- Analysis of extensive global clinical trials involving over 40,000 individuals.
- Evaluation of antihypertensive therapy's impact on morbidity and mortality.
- Review of trial methodologies and outcome reporting.
Main Results:
- Trials have provided significant insights into hypertension control.
- Some trials yielded inconclusive results, particularly regarding coronary artery disease.
- Current analyses may not fully support practicing physicians' decision-making.
Conclusions:
- Clinical trial data is essential for understanding hypertension treatment.
- Broader outcome measures beyond mortality are necessary for clinical utility.
- Refined analysis of trial data can enhance treatment guideline development.
Abstract:
Extensive clinical trials have been carried out to test the effectiveness of antihypertensive therapy in controlling high blood pressure and in reducing the morbidity and mortality associated with hypertension and related cardiovascular and cerebrovascular disease. These trials have studied more than 40,000 individuals in programs worldwide. Although they answered many important questions, some of these trials have failed to produce conclusive results concerning certain issues, such as the results of treatment on coronary artery disease. The medical community has come to rely on clinical trials in evaluating the treatment of many different chronic diseases, and this methodology has become the accepted means of evaluating therapy. Analyses of the clinical trials on hypertension and their implications should review factors other than fatal and non-fatal end points if their results are to be useful for the practicing physician in making treatment decisions.